The Ebola Virus. By Emilio Saavedra

Similar documents
Media centre Ebola virus disease

Ebola Virus Patient Advisory

Genus Ebolavirus is 1 of 3 members of the Filoviridae family (filovirus), along with genus Marburgvirus and genus Cuevavirus.

UTSW/BioTel EMS TRAINING BULLETIN October EMS TB Ebola Virus Disease (EVD)

12 June The average EVD case fatality rate has been around 50 per cent.

saipem Ebola virus diseases EVD August 2014

Confronting Ebola. Keeping NY patients and healthcare workers safe and healthy

Ebola Virus Disease: the Facts, Response & the Way Forward. Dr. Abraham Idokoko Ebola Emergency Operations Centre (EEOC), Lagos.

Questions and Answers on Ebola

Ebola Virus Disease. Global Epidemiology and Surveillance in Hong Kong. as of 13 August 2014

Summary of current outbreak in Guinea, Liberia and Sierra Leone

Marburg and Lassa viruses ศาสตราจารย ดร.พ ไลพ นธ พ ธว ฒนะ

Marburg virus disease

Ebola Virus Disease (EVD) Essential information

Ebola Virus Disease(EVD)

EBOLA. Harford County Health Department October 22, 2014

Viral Hemorrhagic Fevers

Ebola. Wessex CPD Event 14/11/14. Dr Ishani Kar-Purkayastha, CCDC, Wessex PHE Centre Tel:

EBOLA VIRUS AWARENESS

EBOLA 101. Update for EMS System Stakeholders. Eric M. Rudnick, MD, FACEP, FAAEM Medical Director Nor Cal EMS Version 10/25/2014

EDUCATIONAL COMMENTARY EMERGING INFECTIOUS DISEASES WITH GLOBAL IMPACT

Key Points Ebola Virus Disease, West Africa Newly updated information is indicated in red

U.S. CDC s Response to the Ebola Outbreak

Ebola Epidemic in Coastal West Africa Overall Situation

EBOLA FACTS. During this outbreak, most of the disease has spread through human-to-human transmission.

U.S. and British troops head to West Africa to help fight Ebola virus

Making Sense Of The Ebola Virus

Ebola Virus Introduction

Acquired Immune Deficiency Syndrome (AIDS)

Ebola: 22,000 cases, 8700 deaths. Enterovirus D68: 1100 cases, 14 deaths. Chikungunya virus: almost a million cases in the Western Hemisphere

Ebola Virus Transmission

Ebola Virus Diseases

Ebola Exposure (Version )

VIRAL HEMORRHAGIC FEVER (VHF)

Appendix B: Provincial Case Definitions for Reportable Diseases

Statements about Ebola: True or false? Part 1 Commented version for trainers only!

TRAVEL ADVISORY TO PREVENT THE IMPORTATION OF EBOLA INTO SOUTH AFRICA

Ebola Vaccines and Vaccination

EMERGING INFECTIOUS DISEASES DISCLOSURES EMERGING NONE

EBOLA INFORMATION KIT 20 to 26 October 2014 MEMBERS NEWS HUNTING SERVICES FUND LEGISLATION CALENDAR GENERAL SHOP POPULAR ARTICLES

Thank You to Our Partners. Law Enforcement Fire Services Emergency Management Public Health Behavioral/Mental Health

Provider Health & Safety Alert Ebola Virus Disease September 30, 2014

OUR COMMUNITY: OUR WORLD: ONE HEALTH. Ebola : Geomedicine Conference

TRAVEL ADVISORY TO PREVENT THE IMPORTATION OF EBOLA INTO SOUTH AFRICA

CE Unit. Viruses and Vaccines

Infectious Disease Outbreaks in confined spaces

Zika Virus Update for Emergency Care Providers

EBOLA & OTHER VIRUSES IN THE NEWS EBOLA VIRUS, CHIKUNGUNYA VIRUS, & ENTEROVIRUS D68

WHO SOUTHERN SUDAN HEALTH UPDATE May 2004

Grace Kubin, Ph.D. 10 th Annual Alabama Laboratory Meeting 2015

MEEGID XII. Ebola viruses: from the wild to humans

Viral Hemorrhagic Fevers CDC, AFIP

Modeling the Effects of Policy Changes on the Spread of Ebola New Mexico Final Report April 5, 2016 Team#: 112 Saturday Science and Math Academy Team

UNICEF s Response to the Ebola Crisis. Presenta(on to the Execu(ve Board, Informal Session, 11 September 2014

Ebola Virus Disease: Occupational Safety and Health

Information for Primary Care: Managing patients who require assessment for Ebola virus disease Updated 17 Oct 2014

Palliative Care in Ebola

GOAL. Disclosure. Objectives 11/12/2014. Epi 101: Basic Epidemiological Definitions and Principles for Non-Epidemiologists

CIRCULAR LETTER No

CE Unit 7. Viruses and Vaccines

Ebola Outbreak deadly infectious diseases as a potential major threat. Dilys Morgan

EBOLA VIRUS Guidance for Michigan local health departments and healthcare providers

Case study: Epidemic modelling in real life

Ebola virus crisis. Prof. Viktor Volchkov. Molecular basis of viral pathogenicity

West Nile Virus. By Frank Riusech

The presenter has no potential or actual conflicts of interest and no relevant financial relationships to maters regarding or related to Ebola.

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

Yellow fever. Key facts

Dr. Johnmark Opondo MB. ChB. (Nairobi UON), MPH ( Emory) Deputy Medical Health Officer Saskatoon Health Region

LECTURE topics: 1. Immunology. 2. Emerging Pathogens

Ebola Virus Disease. What the physician needs to know. (Overview, Transmission and Clinical Features)

Slide 1. Slide 2. Slide 3 EBOLA 2014 WEST AFRICA CENTRAL AND EAST AFRICA. Hosted by: Bhagavatula Ramakrishna, M.D.

Viral Hepatitis - Historical Perspective

Updates in Infectious Diseases. Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016

What s Lurking out there??????

PROFESSOR DAME SALLY C DAVIES CHIEF MEDICAL OFFICER CHIEF SCIENTIFIC ADVISER

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 6, 13 September 2012

ZIKA VIRUS OUTBREAK. JANET B. EDDY M.D. KU-WICHITA PGY2 OBSTETRICS AND GYNECOLOGY RESIDENCY Dominican Republic 2016

Influenza. By Allison Canestaro-Garcia. Disease Etiology:

The Struggle with Infectious Disease. Lecture 5

EBOLA VIRUS DISEASE. Page 1

Epidemic Ebola Virus Disease Understanding, demystifying and controlling a frightening disease Republic of Guinea, 2014

Distribution: As Appendix 1 Dr Ruth Hussey, Chief Medical Officer, Welsh Government Date: 10 October Ongoing Ebola outbreak in West Africa

Figure 1: Ebola Virus strengthens the framework for a scaled-up response.

PRESS STATEMENT ON MARBURG VIRUS DISEASE

Acute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract).

Hepatitis A Surveillance Protocol

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 4 Issue 3, 23 May 2014

Influenza-Associated Pediatric Mortality rev Jan 2018

EBOLA. Christina Liscynesky, MD Assistant Professor of Internal Medicine Division of Infectious Diseases Associate Medical Director of Epidemiology

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

CDC Support for Exit Screening & Lessons Learned for Preparedness

Epidemiology of Lassa Fever

USING ADVANCED GENOMIC ANALYSIS FOR POTENTIAL HAEMORRHAGIC FEVER CAUSATIVE AGENTS. J H Kofi Bonney, PhD

Chapter 23 Lassa virus. Lassa virus is a RNA virus belonging to the family of Arenaviridae. As the causative agent of

Chapter 14 Part One Biotechnology and Industry: Microbes at Work

Fever virus going around 2017

PUBLIC HEALTH SIGNIFICANCE SEASONAL INFLUENZA AVIAN INFLUENZA SWINE INFLUENZA

ZIKA VIRUS. Epic and aspects of management

WHAT S NEW WITH OSHA AND INFECTION CONTROL?

Transcription:

The Ebola Virus By Emilio Saavedra Etiological Agents: Ebolavirus is the etiologic agent. [1] There are four main families of viruses that are agents of Ebola (hemorrhagic fever). [1] These four families are filoviruses, bunyaviruses, arenaviruses and flaviviruses. [1] The agents that are the most well- known include Ebola virus, dengue virus and Margburg virus. [1] Transmission: The first infection of a person with Ebola is usually from a spillover event where that person comes in contact with an animal infected with the Ebola virus. [2] Transmission of the Ebola virus from person to person is through direct contact with an infected person, or direct contact with bodily fluids of an infected person. [2] The bodily fluids may include blood, sweat, semen, breastmilk, mucous, urine, saliva vomit etc. [2] Men who have recovered from Ebola can infect their sexual partners with their semen. [2] Reservoirs: Some mammals are believed to be reservoirs for the Ebola virus. [3] These animals include bats, rodents and monkeys. [3] Bats are considered to be the most likely reservoir of the Ebola virus. [3] General Characteristics of MO (specific): Ebola virus belongs to the family Filoviridae in the order Mononegavirales. [4] Filoviruses are non- segmented, enveloped negative- stranded RNA viruses. [4] They have varying morphology. Ebola virus particles vary in length, but have a diameter of 80nm. [4] The genome consists of seven genes in the order 3 leader, nucleoprotein, virion protein 35, VP40, glycoprotein, VP30, VP24, RNA- dependent RNA polymerase (L)- 5 trailer. [4] Key Tests for identification: The tests that can be done to identify Ebola are, antibody- capture enzyme- linked immunosorbent assay (ELISA), antigen- capture detection tests, serum neutralization test, reverse transcriptase polymerase chain reaction (RT- PCR) assay, electron microscopy and virus isolation by cell culture. [5]

Signs and Symptoms of disease: The Ebola virus incubation period is 2 to 21 days. [5] Humans become infectious when they develop symptoms. [5] The first symptoms include a sudden onset of fatigue, muscle pain, fever, headache and sore throat. [5] These symptoms are followed by diarrhea, vomiting, rash, symptoms of impaired liver and kidney function, and possibly internal and external bleeding. [5] Laboratory findings may include elevated liver enzymes and low platelet and white blood cell counts. [5] Historical Information: The first known Ebola virus outbreak was in 1976 in Sudan and the Democratic Republic of the Congo (DRC). [6] The next known outbreak occurred in 1994. [6] Since then, Ebola outbreaks have been occurring more frequently. [6] There is currently an outbreak occurring in West Africa and it is the largest known Ebola outbreak to date. [6] The countries affected by this current outbreak are Guinea, Sierra Leone and Liberia. [6] There was a small outbreak in August of 2014 in the Democratic Republic of Congo. [6] There were also three smaller outbreaks in 2012. [6] These outbreaks were in the Democratic Republic of Congo and Uganda. [6] Two of the three outbreaks that year were in Uganda. [6] Virulence Factors: It is largely unknown what the virulence factors of filoviruses are and their exact functions. [7] The virulence factors are currently under investigation. [7] Filoviruses can infect and alter a variety of cells, sometimes killing them. [7] Filoviruses infect the liver, the immune system and the adrenal gland. [7] Hemorrhagic fever results, causing blood clots to form in the circulatory system, which may lead to multi- organ failure, blood vessel weakening and becoming permeable, which can cause bleeding and swelling, and altering of the immune system. [7] The altered immune cells release massive amounts of inflammatory molecules. [7] These molecules can increase the permeability of blood vessels. [7] This may cause the some cells to apoptose and send the body into shock. [7] Control/Treatment: To date, there is no FDA- approved vaccine or medicine available for Ebola. [8] Some treatments can increase the chance of an infected person s chance of survival. [8] These treatments include providing intraveinous

fluids and balancing electrolytes, maintaining oxygen status and blood pressure, and treating other infections if they occur. [8] There are measures that can be taken to control the spread of Ebola. [9] Practice careful hygiene. [9] Avoid contact with bodily fluids. [9] Wash hands with soap and water or alcohol- based hand sanitizer. [9] Do not handle items that have come in contact with the bodily fluids of an infected person. [9] Do not handle the body of a person who has died of Ebola. [9] Avoid contact with infected fruit bats or primates, or semen of a man who has had Ebola. [9] Prevention/Vaccine info: Prevention recommendations include meticulous attention to personal protective equipment and environmental cleaning during patient care. [10] There are no FDA- approved vaccines to protect against EVD in humans. [10] There are clinical trials being done for vaccine candidates. [10] These are ChAd3- ZEBOV, rvsv- ZEBOV, Ad26- EBOV and MVA- EBOV. [10] Local Cases or Outbreaks (with incidence figures): On September 30 th, 2014, a man in a Dallas, Texas hospital became the first person in the United States was diagnosed with Ebola. [11] On October 12 th, a second person, a health care worker who had cared for the patient tested positive for Ebola. [11] October 15 th, 2014 a second health care worker tested positive for Ebola. [11] The health care worker had also cared for the original patient. [11] The Ebola outbreak in Texas appears to have ended, however more than 200 travelers have been monitored for symptoms in Texas. [11] Global Cases or Outbreaks (with incidence figures): As of March 20, 2015, there have been 26,757 cases of Ebola (suspected, probable and confirmed) worldwide. [12] There have been 14,954 laboratory- confirmed cases worldwide. There have been 11,079 total deaths worldwide. [12] References: 1. Viral Hemorrhagic Fever (Ebola). 7 Nov. 2014 Washington State Guidelines for Notifiable and Surveillance. 5 May 2015 http://www.doh.wa.gov/portals/1/documents/5100/420-126- Guideline- Ebola.pdf#nameddest=casedef

2. Transmission. 24 April 2015. Center for Disease Control and Prevention. 5 May 2015 http://www.cdc.gov/vhf/ebola/transmission/index.html 3. About Ebola Virus Disease. 24 April 2015. Center for Disease Control and Prevention. 5 May 2015. http://www.cdc.gov/vhf/ebola/about.html 4. Feldmann, Heinz, and Thomas W Geisbert. Ebola Haemorrhagic Fever. Lancet 377.9768 (2011): 849 862. PMC. Web. 5 May 2015. http://www.ncbi.nlm.nih.gov/pmc/articles/pmc3406178/ 5. Ebola Virus Disease. WHO. April 2015. World Health Organization. 8 May 2012 http://www.who.int/mediacentre/factsheets/fs103/en/ 6. Ebola Overview: History, Origins and Transmission. 29 January 2015. Public Health of England. 8 May 2015 https://www.gov.uk/government/publications/ebola- origins- reservoirs- transmission- and- guidelines/ebola- origins- reservoirs- transmission- guidelines 7. Ebola Fact Sheet. 2013. Federation of American Scientists. 8 May 2015 http://fas.org/programs/bio/factsheets/ebola.html 8. Ebola Virus Disease. 2014. Association for Professionals in Infection Control and Epidemiology. 11 May 2015 http://www.apic.org/professional- Practice/Practice- Resources/Ebola- virus- disease#/121187 9. Prevention. 24 April 2015. Center for Disease Control and Prevention. 5 May 2015 http://www.cdc.gov/vhf/ebola/prevention/index.html

10. Ebola Vaccines, Therapies and Diagnostics. WHO. April 2015. World Health Organization. 8 May 2012 http://www.who.int/medicines/emp_ebola_q_as/en/ 11. Ebola in Texas. Texas Department of State Health Services. 11 May 2015 http://www.texasebola.org/ 12. 2014 Ebola Outbreak in West Africa- Case Counts. 10 May 2015. Center for Disease Control and Prevention. 11 May 2015 http://www.cdc.gov/vhf/ebola/outbreaks/2014- west- africa/case- counts.html